BioEcho receives CE-IVD mark approval for SARS-CoV-2 RNA extraction kit
(PresseBox) - BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line, which has been classified as a medical device Class A IVD in the European Union.
To obtain this certification the products have to comply with the regulation 2017/746 of the European Parliament and of the Council from April 2017 on in vitro diagnostic medical devices (IVDR).
"Receiving the CE-IVD mark for our viral RNA and DNA extraction kit does not only officially substantiate our internally set quality standards but also facilitates the global fight against COVID-19 by providing faster test solutions", said Dr. Frank Sch
In current times, the CE-mark is especially valuable because validation processes in diagnostic laboratories are time-consuming. The CE-mark facilitates easy and quick integration into the diagnostic laboratory routine.
EchoLUTION RNA extraction method speeds up SARS-CoV-2 PCR tests
The EchoLUTION Viral RNA/DNA Swab Kit allows a very fast and efficient viral RNA purification within just 5 minutes. Unlike conventional bind-wash-elute methods, all impurities are held back by the purification matrix and the nucleic acid is running through in a single purification step. This results in highly pure RNA for extremely reliable RT-qPCR with no inhibitory effects or reagent carry-over. The speed of the extraction method contributes to faster COVID-19 tests in general. The system is compatible with commonly available transport media.
BioEcho has built a highly flexible working environment, including scalable production capacities, which has enabled them to avoid any backorder situations even during these periods of high demands.
The products are available in Germany via direct sales and worldwide via distributors or upon request.
BioEcho Life Sciences GmbH is a dynamically growing, innovative company founded in 2016 in Germany by a team of industry experts from the field of nucleic acid purification. The company uses its know-how to overcome the limitations of conventional methods in molecular biology.
Just like its customers, BioEcho''s mission is to always be one step ahead. Therefore, they develop and produce next-generation technologies and products to enable molecular biology and diagnostic laboratory workflows of higher convenience, higher robustness, and higher sustainability due to less hazardous reagents and reduced plastic waste.
One of BioEcho''s assets is a close customer relationship. For more information about the EchoLUTION Viral RNA/DNA Swab Kit, please visit the company website or contact the BioEcho team for any request via contact(at)bioecho.de.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
BioEcho Life Sciences GmbH is a dynamically growing, innovative company founded in 2016 in Germany by a team of industry experts from the field of nucleic acid purification. The company uses its know-how to overcome the limitations of conventional methods in molecular biology.Just like its customers, BioEcho''s mission is to always be one step ahead. Therefore, they develop and produce next-generation technologies and products to enable molecular biology and diagnostic laboratory workflows of higher convenience, higher robustness, and higher sustainability due to less hazardous reagents and reduced plastic waste.One of BioEcho''s assets is a close customer relationship. For more information about the EchoLUTION Viral RNA/DNA Swab Kit, please visit the company website or contact the BioEcho team for any request via contact(at)bioecho.de.
Datum: 10.05.2021 - 05:48 Uhr
Sprache: Deutsch
News-ID 1566945
Anzahl Zeichen: 3312
contact information:
Contact person:
Town:
Germany, Cologne
Phone:
Kategorie:
Handcrafts
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioEcho receives CE-IVD mark approval for SARS-CoV-2 RNA extraction kit
"
steht unter der journalistisch-redaktionellen Verantwortung von
BioEcho Life Sciences GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
